Oxford-AstraZeneca researchers attempt to battle variants

Researchers at Oxford-AstraZeneca are working on a more effective shot to tackle new coronavirus variants. The testing comes as the company conducts U.S. trials to present for FDA approval. CBS News foreign correspondent Charlie D’Agata reports. Source